Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

NCT00078494 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

99

Enrollment

NIH

Sponsor class

Conditions

Nasopharyngeal Neoplasms

Interventions

DRUG: EBV-LMP-2

Sponsor

National Institutes of Health Clinical Center (CC)